We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement
Analytical Cannabis Logo
×
Home > Policy

Cannabis Policy

Mississippi Legalizes Medical Cannabis

The state governor, Tate Reeves, signed a legalization bill on Wednesday, February 2.

Read More

Testing Cannabis Competitively: A Conversation with the Emerald Cup’s Lab Partner, SC Labs

To learn more about what it means for cannabis labs to partner with competitive cannabis events, and just how involved they are in the judging process, Analytical Cannabis caught up with SC Labs co-founders Jeff Gray and Josh Wurzer.

Read More

Californian Regulator Recalls Cannabis Flower Due to Mold Contamination

A batch of dried cannabis flower has been recalled by California’s Department of Cannabis Control (DCC) after it was found to be contaminated with Aspergillus niger.

Read More

Most Cannabis Consumers Are Confident to Drive When They’re Most Intoxicated, Study Finds

Many cannabis-high drivers consider themselves safe to drive when they’re actually at their most impaired, according to a new study.

Read More

Thailand Moves to Decriminalize Cannabis

Thailand is on its way to becoming the first country in Asia to decriminalize cannabis.

Read More

Delta-8 THC Consumers Consider it “Delta-9’s Nicer Sibling,” Survey Finds

Delta-8 THC products provide all the benefits of delta-9 THC but with fewer adverse effects, according to consumers.

Read More

Price of Cannabis Continues to Fall in Canada After Legalization

Researchers from the University of Waterloo, Ontario, report that the mean price of dried flower from legal sources fell in 2019 and then again in 2020.

Read More

Cannabis “Poisonings” in Children Increased Ninefold After Edibles Were Legalized in Canada, Study Finds

After commercial edibles became legally available in 2019, cannabis-related exposures were seen to be responsible for nearly 10 percent of all ED visits for poisonings in Ontario.

Read More

Canadian Patients Now Have Better Access to Psychedelic-assisted Therapy, Following a Federal Amendment

Doctors in Canada can now request psychedelic-assisted therapies for their patients through a new program, following an amendment to Health Canada’s Special Access Program (SAP).

Read More

 
Advertisement